Anti-VEGF Injections for Diabetic Eye Disease: What to Expect
How Anti-VEGF Injections Treat Diabetic Eye Disease
If you have been diagnosed with diabetic eye disease, you may need a treatment called anti-VEGF injections to protect your vision. These injections are one of the most effective tools available for managing conditions like diabetic macular edema and proliferative diabetic retinopathy, and they have helped many patients preserve and even improve their sight. According to the American Academy of Ophthalmology, anti-VEGF injections stabilize or improve vision in approximately 9 out of 10 patients treated for diabetic eye disease (AAO, 2024). At Greenwich Ophthalmology Associates, our diabetic eye care specialist has extensive experience delivering this treatment with precision and care.
Diabetes can damage the tiny blood vessels in your retina over time, reducing blood flow and oxygen delivery to retinal tissue. In response, your body produces excess vascular endothelial growth factor (VEGF), a protein that signals new blood vessels to grow. Unfortunately, these new vessels are fragile and prone to leaking blood and fluid into the retina. This leakage causes swelling, distortion, and progressive vision loss if left untreated.
Anti-VEGF medications are delivered directly into the vitreous (the gel-like substance that fills the inside of your eye) through a procedure called an intravitreal injection. Once inside the eye, the medication binds to VEGF molecules and prevents them from triggering new vessel growth and fluid leakage. By reducing swelling in the macula and halting the proliferation of abnormal blood vessels, anti-VEGF injections help stabilize and often improve your vision.
Anti-VEGF therapy is used to treat two primary forms of diabetic eye disease. Our diabetic eye care specialist evaluates the specific type and severity of your condition to determine whether anti-VEGF injections are the most appropriate treatment for your situation.
- Diabetic macular edema (DME), where fluid accumulates in the central retina and causes blurred or distorted vision
- Proliferative diabetic retinopathy (PDR), where fragile new blood vessels grow on the surface of the retina and can bleed or cause retinal detachment
What Medications Are Used for Diabetic Eye Injections
Several anti-VEGF medications are FDA-approved or widely used for treating diabetic eye disease. Avastin (bevacizumab) was originally developed as a cancer treatment and is used off-label for diabetic eye disease due to its effectiveness and lower cost. Lucentis (ranibizumab) was the first anti-VEGF medication specifically designed and FDA-approved for use in the eye, engineered to penetrate retinal tissue efficiently. Eylea (aflibercept) binds to multiple forms of VEGF as well as placental growth factor, providing a more sustained effect for some patients.
Vabysmo (faricimab) is a newer bispecific antibody that targets both VEGF and angiopoietin-2, another protein involved in blood vessel instability. Clinical trials have shown that Vabysmo can extend the time between injections for some patients, potentially reducing the overall treatment burden while maintaining strong visual outcomes.
The choice of anti-VEGF medication depends on several factors, including the severity of your condition, your treatment history, how your eye responds to initial injections, and insurance coverage. We discuss these options with you so that together we can select the medication that best fits your clinical needs and circumstances.
How Often Are Diabetic Eye Injections Needed
Most treatment plans begin with a loading phase of monthly injections, typically once every four weeks for three to six months. This initial series helps build up an effective concentration of the medication inside the eye and allows your diabetic eye care specialist to assess how well your retina is responding. Regular imaging during this phase guides decisions about the next steps.
After the loading phase, many patients transition to a maintenance schedule where injections are given less frequently. Depending on your response, treatments may be extended to every six, eight, or even twelve weeks. We use a treat-and-extend approach for many patients, gradually increasing the interval between injections as long as your retina remains stable.
At each visit, we perform optical coherence tomography (OCT) imaging and a thorough retinal examination to evaluate fluid levels, retinal thickness, and overall disease activity. These findings determine whether your current injection interval is appropriate or needs adjustment. Keeping all scheduled appointments is important because missed or delayed treatments can allow fluid to return and vision to decline.
Diabetic eye disease is a chronic condition, and most patients require ongoing treatment over months or years. Some patients eventually achieve stability and can pause injections under careful monitoring, while others need continued treatment to maintain their vision gains. Your regular diabetic eye exams play a key role in guiding long-term management.
What Happens During the Injection
When you arrive, we place numbing drops on the surface of your eye so that you do not feel the needle. An antiseptic solution, typically povidone-iodine, is applied to the eye and surrounding area to minimize infection risk. A small device called a speculum gently holds your eyelids open so you do not need to worry about blinking during the procedure.
The injection itself takes only a few seconds. Using a very fine needle, your diabetic eye care specialist delivers a tiny amount of medication through the white part of your eye (the sclera) into the vitreous cavity. Most patients report feeling only mild pressure rather than sharp pain. The entire appointment, including preparation and observation, usually takes about 15 to 30 minutes.
You may notice some mild redness, a gritty sensation, or small floaters in your vision for a day or two following the injection. These symptoms are normal and typically resolve on their own. We provide aftercare instructions and let you know which symptoms warrant a call to our office. Most patients are able to return to their normal activities, including driving, the same day or the next morning. Your vision will be blurry for several hours after dilation, so bring sunglasses and arrange a ride if possible.
The numbing drops used before the injection are very effective, and most patients describe the experience as far more comfortable than they expected. If you have concerns about discomfort, let us know ahead of time so we can take additional steps, such as using a cold compress or allowing extra time for the anesthetic to take full effect. Over-the-counter artificial tears can help soothe any mild irritation afterward.
Frequently Asked Questions
Many patients experience stabilized or improved vision after beginning anti-VEGF therapy. Results depend on factors like the severity of disease at the time treatment begins, how consistently you attend appointments, and how well your blood sugar is managed alongside your eye treatment.
The most common side effects are mild and temporary, including eye redness, irritation, and floaters. Serious complications are rare but can include elevated eye pressure, inflammation inside the eye, and infection. We take strict sterile precautions at every visit to minimize these risks and provide clear instructions on when to contact us after your injection.
For diabetic macular edema, anti-VEGF injections have largely replaced laser treatment as the first-line therapy because they produce better visual outcomes on average. Laser treatment remains a valuable option for proliferative diabetic retinopathy and may be used alongside injections in certain cases.
Anti-VEGF therapy can improve vision that has been reduced by macular swelling, particularly when treatment begins before permanent retinal damage has occurred. However, vision loss caused by long-standing swelling, ischemia (lack of blood flow), or advanced scarring may not be fully reversible. This is one of the reasons early detection through routine screening and preventive care is important for patients with diabetes.
There is no set endpoint for anti-VEGF therapy. Some patients need injections for several years, while others achieve enough stability to extend or pause treatment under close monitoring. We personalize every treatment plan based on how your retina responds over time, with the goal of maintaining your vision with the fewest injections necessary.
What our Patients say
4.8
Reviews
(3,408)